Evofem Biosciences (EVFM) FCF Margin (2020 - 2026)
Evofem Biosciences (EVFM) reported FCF Margin of -119.26% for Q2 2026, down 58.76 percentage points from -60.50% a year earlier and down 374.98 percentage points from the prior quarter.
Evofem Biosciences (EVFM) FCF Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evofem Biosciences' FCF Margin came in at -2.64%, up 27.62 percentage points year-over-year; for FY2025, it was -9.89%, up 10.24 percentage points from FY2024.
- FCF Margin has increased for five consecutive years, with a five-year change of +23999.75 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at -20.14% in FY2024 (+29.11 pp), -49.25% in FY2023 (+370.96 pp), -420.21% in FY2022 (+1394.51 pp) and -1814.73% in FY2021 (+22194.92 pp).
- The Q2 2026 figure ranks as the lowest quarterly FCF Margin since Q4 2022.
- Year over year, FCF Margin gained in five of the last eight quarters, with an average year-over-year change of +27.21 percentage points.
- The high point for year-over-year FCF Margin in five years was Q4 2021 (a gain of 23510.00 percentage points); the low point was Q4 2022 (a drop of 3030.48 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 255.73% (Q1 2026), 0.29% (Q4 2025) and 6.79% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.01% |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | -119.26% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -119.26% |
| Mar 31, 2026 | 255.73% |
| Dec 31, 2025 | 0.29% |
| Sep 30, 2025 | 6.79% |
| Jun 30, 2025 | -60.50% |
| Mar 31, 2025 | 66.27% |
| Dec 31, 2024 | -33.90% |
| Sep 30, 2024 | -10.21% |
| Jun 30, 2024 | -27.43% |
| Mar 31, 2024 | 3.03% |
| Dec 31, 2023 | -3.51% |
| Sep 30, 2023 | -46.24% |
| Jun 30, 2023 | -60.82% |
| Mar 31, 2023 | -85.09% |
| Dec 31, 2022 | -3,627.62% |
| Sep 30, 2022 | -256.95% |
| Jun 30, 2022 | -444.65% |
| Mar 31, 2022 | -493.65% |
| Dec 31, 2021 | -597.14% |
| Sep 30, 2021 | -2,217.52% |
Evofem Biosciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();